Bio-Rad's Q2 Revenues Jump 9 Percent on Strong Dx Sales

The firm's diagnostics business reported double-digit growth, while life science sales grew less than 1 percent, due primarily to weakness in Europe.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories